Tell Us What Brought You Here — In One Line

• In one sentence, what prompted you to explore liquidity for these positions right now?
• Which of the following best describes the portfolio you’re considering selling? Options: Mixed fund interests (multiple PE/VC funds), Single-fund LP stake, Direct private company stakes, GP-led continuation vehicle candidate, Other / hybrid
• Approximate market value of the positions you’re considering (USD)? Options: Under $10M, $10M–$50M, $50M–$250M, $250M–$1B, Over $1B, Prefer to state in a follow-up
• Who is our primary contact on this opportunity and how do they typically like to be engaged (email, briefings, weekly sync)? Options: CIO/Head of Private Markets, Deputy/Portfolio Manager, Treasury/Finance lead, External adviser/placement agent, Other
• Do you currently have an adviser or intermediary managing the sale process? If so, who and what’s their role?

Are You Comfortable Waiting for the Market to Decide?

• If you chose to wait for broader market conditions to (hopefully) improve, what would be the tangible cost or risk to your organization?
• How fixed is your timeline—what is the earliest and latest acceptable close date? Options: Close within 2 weeks, 2–6 weeks, 6–12 weeks, 3–6 months, 6+ months / flexible
• What internal or external events (e.g., audits, budget cycles, board review, M&A, regulatory deadlines) are driving your timeline?
• What happens if you do not achieve liquidity on your desired timeline—how would that affect funding, reporting, or strategic plans?
• On a scale from 'purely opportunistic' to 'must-solve now', where does this need sit for you? Options: Must-solve now, High priority this quarter, Preferable this year, Opportunistic / flexible

What Would ‘Winning’ Look Like — Beyond Just a Number?

• Aside from headline price, what are the non-negotiable outcomes you need to call this a success (e.g., certainty of close, zero market leakage, tax outcome, LP relationships preserved)?
• Which of these success signals are most important to you? Options: Highest achievable price, Certainty of close without retrade, Speed to close, Discretion and minimal market exposure, Preservation of LP/GP relationships, Favorable tax/timing outcomes
• Do you need post-close arrangements (e.g., earnouts, deferred consideration, rollover in continuation vehicle)? If yes, what form do you prefer? Options: All-cash, Partial deferred consideration, Earnout tied to asset performance, Rollover into continuation vehicle, Preferred equity / structured payment, Open to discussion
• Is maintaining an ongoing relationship with the GP or remaining exposure to upside a priority for you? If so, why? Options: Yes — strategic reasons or upside, Yes — governance/relationship reasons, No — desire full exit, Maybe — depends on terms
• What would be an acceptable range around your target price (e.g., within 5%, 10–20%, more), and what feels like a deal-breaker? Options: Within 0–5%, 5–10%, 10–20%, Any meaningful discount acceptable for speed/certainty, Not sure—need adviser input

What Keeps You Up at Night About Selling These Positions?

• Which of these potential deal risks concerns you most right now? Options: LP consent delays or refusals, GP pushback / reputational risk, Valuation disputes, Tax or regulatory exposures, Market signaling to stakeholders, Operational burden / data quality
• Have any of these positions ever been subject to transfer restrictions, side letters, or specific consent clauses we should know about? Options: Yes—material restrictions exist, Yes—minor/standard restrictions, No known restrictions, Unsure / need to check
• Have you previously explored a sale of these assets? If yes, what stopped the process or created problems?
• How would a public or leaked process impact you internally or externally (board, beneficiaries, portfolio companies)? Options: Significant negative impact, Moderate impact; manageable, Minimal impact, Prefer not to disclose publicly
• Do you anticipate any tax, regulatory, or compliance hurdles we should flag early? Options: Yes—tax issues likely, Yes—regulatory/compliance likely, No known hurdles, Unsure—need review

How Much Control Over Terms Do You Need (and From Whom)?

• Which deal structures are permissible under your mandate and approvals? Options: All-cash sale, Partial deferred consideration, Earnout / contingent payments, Rollover into GP-led continuation, Preferred equity / structured financing, Other / bespoke
• Are you allowed to accept contingent or performance-based components (earnouts), and if so, what limits apply? Options: No contingents allowed, Limited contingents allowed (specify), Contingents acceptable with board sign-off, Unsure—need governance check
• Would you require an exclusivity period with a preferred counterparty, and for how long? Options: No exclusivity, Short exclusivity (1–2 weeks), Medium exclusivity (2–4 weeks), Long exclusivity (4+ weeks) with board approval, Undecided / depends on terms
• Are there internal investment committee, board, or regulatory approvals needed to complete the sale? Who signs final approval? Options: Investment committee, Board of directors, CIO or delegated officer, Treasury/Legal sign-off, External adviser must approve, Other
• Do you have any absolute deal term exclusions (e.g., no GP-led continuation, no earnouts, no public disclosure)? Please list.

If Price and Timing Were at Odds, What Would You Trade Off?

• If offered faster close but lower upfront proceeds, would you consider it? What’s the minimum trade-off you’d accept? Options: Yes—speed prioritized over some price (specify), Maybe—depends on structure, No—price outweighs speed, Not sure—need examples
• Rank the following priorities when evaluating offers (1 most important to 5 least): Price, Certainty of Close, Speed, Discretion, Tax/Accounting outcome. Options: 1, 2, 3, 4, 5
• Would you accept a larger deferred component if it materially improved headline pricing today? Options: Yes—open to meaningful deferred, Maybe—limited deferred only, No—prefer cash up front, Only with strong legal protections
• Have you modeled the accounting or P&L impacts for different timing/structure scenarios? If so, what surprised you?

Who Actually Holds the Keys to Saying Yes?

• List the people or committees that must approve this transaction and their typical decision timeline.
• Are there external stakeholders whose views matter (e.g., regulators, major beneficiaries, donors), and what influence do they exert? Options: Regulators, Major beneficiaries/donors, LP advisory committees, Trustees/oversight boards, None / minimal external influence
• Historically, how long does your approval chain take from term agreement to final sign-off? Options: Under 1 week, 1–2 weeks, 2–4 weeks, 1–3 months, Longer / varies
• Who on your team can act as the day-to-day counterpart for diligence questions and quick decisions? Options: CIO/Head, Deal lead / Portfolio Manager, Legal counsel, External adviser, No dedicated counterpart yet
• Are there anticipated blackout periods (board vacations, audit windows, regulatory submission dates) that would slow approvals? Options: Yes—specific blackout dates, Possibly—tbd, No known blackout periods

Show Us How This Can Be Simple — What Would Make It Effortless?

• What level of involvement do you want from our team—fully managed execution, collaborative partnership, or high-level pricing only? Options: Fully managed (we run process), Collaborative (you and your adviser), Pricing/indicative only, Undecided
• Which of these deliverables would reduce your burden most quickly? Options: Binding indicative within two weeks, Pre-populated template for LP consent requests, Valuation summary by asset, Deal term sheet and waterfall model, Data-room checklist and upload assistance
• What format is your data in and how ready is it for diligence (e.g., deal-level cashflows, capital calls, NAV backing docs)? Options: Data-room ready / well organized, Partially organized (some manual work), Raw spreadsheets / needs standardization, Minimal documentation—will require gathering
• How discreet must we be in marketing this opportunity and what channels should be restricted? Options: Strict confidentiality—no market outreach, Limited outreach to select buyers, Open market process allowed, Follow adviser guidance
• If we propose next steps, what’s a realistic earliest date you could provide a full portfolio file and relevant side letters? Options: Within 3 business days, Within 1 week, 1–2 weeks, 2–4 weeks, Longer / need to coordinate
• What would make you confident enough to accept a binding-indicative offer from us within two weeks? Options: Clarity on transfer mechanics, Satisfactory tax opinion, LP consent path mapped, Robust valuation rationale, Other—please specify

• Current State & Consequence Alignment
• Portfolio Assumptions & Cashflow Calibration (Workshop)
• Valuation Pathways Walk-through (Diagnosis -> Proof -> Validation)
• Structuring & Outcomes Optimization
• Validation Sign-off & Path to Indicative Commit

• Identify any regulatory/tax diligence tasks or LP-consent actions required to make the preferred structure executable.
• If needed, schedule follow-up clarifier sessions for large data gaps or complex direct positions.
• One-line Future State Reminder
• Seller validates that the baseline and alternate valuation pathways accurately reflect their portfolio and priorities.
• Surface which pathway(s) best deliver the defined future state and reduce the quantified consequence.
• Capture any model corrections or missing information necessary for final indicative pricing.
• Deliver the walked-through valuation report with clear annotations tying each output to the seller's stated problem.
• Seller to provide final confirmations or mark corrections for any model inputs within agreed SLA.
• Modeling team to run any additional sensitivity scenarios requested during validation and return updated outputs.
• Recap Validated Pathways
• Agree on 1-2 preferred deal structures to pursue to indicative terms.
• Quantify the net-proceeds, timeline and primary risks for each selected structure.
• Introductions & Objectives
• Prepare an indicative term sheet for the seller's preferred structure(s) including pricing range, payment mechanics, and key conditions.
• Engage external tax/regulatory advisors if required and scope deliverables and timing.
• Map LP consent path and prepare a communications plan if LP engagement is needed.
• Executive Recap
• Seller provides explicit validation of the model inputs and chosen structure(s) to proceed to indicative pricing.
• Clear list of any remaining open items and owners with firm deadlines ahead of indicative pricing.
• Mutually agreed timeline to issue binding indicative pricing and date for the Solution Scope meeting.
• Seller to provide final sign-off on validated inputs and a non-binding go/no-go signal to proceed to indicative pricing.
• CustomerNode to schedule the Solution Scope meeting and circulate pre-reads including the preliminary term sheet and data summary.
• Document and escalate any unresolved items that could materially change pricing (with responsible parties and deadlines).
• Produce a single clear current-state sentence describing the seller's portfolio and pain point.
• Agree and numerically estimate the consequence (cost/time/risk) of not securing liquidity within the target timeline.
• Confirm decision-makers, delegate data owners, and agree on required data deliverables for the modeling phase.
• Seller to provide the full portfolio position list, recent cashflow history, and any transfer restriction documents within 3 business days.
• CustomerNode team to draft the one-sentence current-state statement and consequence estimate and circulate for seller confirmation.
• Assign primary points of contact for data questions and sign-off (names and contact info).
• Recap & Objective of Workshop
• Lock the position-level cashflow assumptions for the baseline and 2 alternate scenarios.
• Agree the sensitivity ranges and the primary value drivers to spotlight in the experience.
• Identify and assign owners to resolve any data gaps before modeling begins.
• Modeling team to ingest seller data and return a preliminary input workbook with assumptions highlighted for confirmation.
• Seller to confirm or correct highlighted assumptions within agreed SLA (e.g., 48 hours).
• Structure Options Overview
• Model Methodology Recap
• Data Walk-through
• Validation Review
• One-sentence Current State
• Net-Proceeds & Timing Comparison
• Cashflow Assumptions Calibration
• Baseline Valuation Walk-through
• Quantify Consequences
• Commitment Signal Request
• Next Steps & Timeline to Indicative Pricing
• Alternate Pathways & Trade-offs
• Sensitivity Parameters
• Risk & LP Consent Paths
• Decision Roles & Timeline
• Tie Back to Consequences
• Seller Trade-off Discussion & Selection
• Validation Checkpoints
• Pre-work & Data Checklist
• Confirm Communication & Confidentiality Rules
• Validation Pauses
• Open Clarifying Questions

• Deliver binding indicative offer
• Deliver bottom-up portfolio valuation model
• Maintain confidential due-diligence data room
• Draft and negotiate transfer agreements
• Manage LP advisory committee consents
• Structure preferred equity and earnouts
• Close purchase and funds transfer
• Execute GP-led continuation vehicle close
• Process fund-interest novation and registration
• Administer escrow and deferred payments
• Transfer direct private company stakes
• Provide post-closing reporting package

Deliver binding indicative offer

• What is the target timing for receiving a binding indicative offer? Options: Within 48 hours, Within 1 week, Within 2 weeks, Flexible / no hard deadline
• What pricing basis should the indicative offer reference? Options: NAV / reported value, Discount to NAV, Fixed cash price, Hybrid (cash + deferred/earnout)
• Does the seller require the indicative offer to be contractually binding (e.g., with exclusivity or breakup fee provisions)? Options: Yes - binding with exclusivity, Yes - binding without exclusivity, Indicative only, non-binding, Unsure - need guidance
• Which portfolio scope should the offer cover (list funds, assets or provide aggregate description)?
• Are there any mandatory gating conditions that must be excluded/included in the offer (e.g., regulatory approvals, LP consents)? Options: LP consents required, Regulatory approval required, No gating conditions requested, Other - please specify
• What level of confidentiality/disclosure is acceptable for the offer publication and counterparty list? Options: Strict confidentiality - NDA before offer, Limited disclosure to advisers only, Public process acceptable, Unsure

Deliver bottom-up portfolio valuation model

• Which outputs are required from the bottom-up valuation model? Options: Estimated fair value per interest, Projected cashflow waterfall, IRR and TVPI scenarios, Sensitivity and downside cases, All of the above
• What historical and source data are available to build the model (e.g., capital calls/distributions, financial statements, cap tables)? Options: Full transaction-level cashflows, Summary NAV & schedules, Partial data - requires collection, No data - seller needs data collection support
• Which valuation methodology do you prefer or require (select all that apply)? Options: Discounted cash flow / cashflow modeling, Market comparables, Option-implied / scenario-based, GP-provided valuations / mark-to-market, No preference
• Are there specific valuation policies or accounting standards to follow (e.g., IFRS fair value, US GAAP, internal policy)? Options: IFRS, US GAAP, Internal policy - provide details, No specific requirement
• Do you require model auditability and supporting documentation for internal or external review? Options: Yes - full audit trail and assumptions, Yes - summary documentation only, No - model for internal use only
• What scenario coverage do you need (base, upside, downside, stressed) and how many years of projection? Options: Base only, Base + downside, Base + downside + upside, Full stress testing (multiple scenarios)

Maintain confidential due-diligence data room

• Do you already have a virtual data room (VDR) or do you need one provisioned? Options: Existing VDR - provide access, Need new VDR provisioned, Prefer secure file transfer / bespoke solution
• Which document access controls are required? Options: Role-based permissions, Download disabled / watermarking, Time-limited access, Full access with logging
• What categories of documents will be uploaded (e.g., LPAs, audited financials, cap tables, side letters, tax documents)?
• Does the seller require NDAs, two-way confidentiality or staged disclosure for different audiences? Options: NDA required before any access, Two-way NDA (mutual), Staged disclosure by bidder tier, No NDA required beyond process confidentiality
• Are there any regulatory, data residency, or encryption requirements for the VDR? Options: EU / GDPR constraints, Local regulator constraints (specify), Encryption at rest & in transit, No special requirements
• What is the expected timeline for making materials available and for bidder access? Options: Immediate (within 48 hours), Within 1 week, Within 2 weeks, Flexible / TBD

Draft and negotiate transfer agreements

• What transfer agreement template should be used or adapted (purchase agreement, assignment and assumption, novation)? Options: Seller counsel template, Buyer counsel template, Broker/adviser template, No template - draft from scratch
• Which commercial terms must be reflected in the agreement (price adjustment mechanics, reps & warranties, indemnities, escrow)? Options: Price adjustment mechanics, Reps & warranties, Indemnities / caps, Escrow / holdbacks, All of the above
• Will the seller require limited representations for unknown items or a knowledge-qualified disclosure schedule? Options: Yes - limited reps with disclosure schedule, No - full reps expected, Prefer middle-ground - negotiable
• Who will lead negotiations and provide legal redlines (seller counsel, buyer counsel, or platform-assisted)? Options: Seller counsel, Buyer counsel, Platform-assisted standard redlines, Adviser-led coordination
• Are there any deadlines for signing or milestone dates that must be in the agreement? Options: Hard close date required, Signing window preferred, Milestone-based timeline (specify)
• Do transfers require any bespoke tax or regulatory language (e.g., withholding clauses, FATCA, local transfer restrictions)? Options: Yes - tax wording required, Yes - regulatory approval clauses required, No special clauses required, Unsure - need counsel advice

Manage LP advisory committee consents

• Does the portfolio include fund interests that require LP or LPAC consent prior to transfer? Options: Yes - LP consents required, Yes - LPAC consent required, No consents required, Unsure - need confirmation
• What is the consent threshold or voting rule specified in the governing documents? Options: Majority consent, Supermajority (e.g., 66%+), Unanimous, Varies by fund - provide details
• How many LPs or advisory committee members will need to be engaged and what are their contact constraints?
• What materials are required to shepherd consent (e.g., valuation memo, side-letter summaries, buyer profile)? Options: Valuation memo, Buyer background and transaction documentation, Copy of transfer agreement, All of the above
• What is the expected timeline to obtain consents and are there any known holdouts or sensitive LPs? Options: Less than 2 weeks, 2-4 weeks, 4+ weeks, Unknown / varies
• Would you like the platform to coordinate LP communications, provide templated materials, or leave communications to seller/adviser? Options: Platform coordinates communications, Platform provides templates only, Seller/adviser manages communications, Hybrid approach

Structure preferred equity and earnouts

• Are you considering preferred equity, deferred consideration, or earnouts as part of the deal? Options: Preferred equity, Deferred consideration, Earnout tied to exit performance, None of the above / cash only
• What percentage of consideration are you open to structuring as deferred / earnout? Options: 0% (cash only), 1-25%, 26-50%, 51%+
• What performance metrics should drive earnout payments (e.g., portfolio realizations, fund distributions, valuation milestones)? Options: Realizations/distributions, Valuation milestones (NAV targets), Time-based vesting, Custom KPIs - specify
• What legal mechanics are required for preferred equity (dividend priority, liquidation preference, convertibility)? Options: Dividend priority, Liquidation preference, Convertible into equity, None of these / custom
• Do you require security or collateral to support deferred amounts or earnouts? Options: Yes - security required, Partial security (escrow), No security required, Undecided
• Are there tax or accounting constraints that affect whether you can accept earnouts or preferred equity? Options: Yes - tax constraints, Yes - accounting recognition constraints, No constraints, Need advisor review

Close purchase and funds transfer

• What is the target legal closing date or closing window? Options: Specific hard date, Within a defined week window, After satisfaction of CPs (TBD), Flexible
• What funding mechanism will be used for the purchase price (immediate wire, escrow release, staged funding)? Options: Immediate wire transfer, Escrow release on conditions, Staged funding / tranches, Combination
• Are there cross-border payment or currency conversion constraints to consider? Options: Yes - FX/cross-border issues, No - domestic only, Unsure - need treasury input
• Do you require a settlement statement and allocation schedule at close (e.g., per-interest allocations, tax allocations)? Options: Yes - detailed allocation schedule, Summary only, No
• Who will act as closing or escrow agent and are there preferred providers?
• Are wire/funds recipient details and bank KYC completed or outstanding? Options: Completed, Partially completed, Not started - need assistance

Execute GP-led continuation vehicle close

• Is the GP-led continuation envisioned as a tender, stapled financing, or preferred-equity-led structure? Options: Tender process, Stapled financing, Preferred-equity structure, Other - specify
• What rollover percentage is anticipated from existing GP/LPs? Options: 0-25%, 26-50%, 51-75%, 76-100%, Unknown / TBD
• Which approval thresholds are required by the GP and the LPs to effect the continuation (e.g., majority in interest, GP approval)? Options: Majority in interest, Supermajority, Unanimous, GP decision with advisory consultation
• What valuation methodology and fairness processes will be used to set rollover and new investor pricing? Options: Independent valuation/fairness opinion, GP-provided valuation with buyer review, Market process with bids, Other - specify
• Are there special governance or fee arrangements for the continuation vehicle that must be negotiated? Options: New fee arrangements, Governance changes required, No change - same terms, Undecided
• Do you require assistance preparing offer materials for LPs and communicating the economics and governance of the continuation vehicle? Options: Yes - full materials + communication, Template materials only, No - GP will provide

Process fund-interest novation and registration

• Does the fund registrar require specific forms or steps for novation/transfer (e.g., signed assignment, GP approval, KYC)? Options: Yes - known registrar requirements, Varies by fund - need review, No - straightforward transfer
• Which registration tasks are needed (transfer deed, amendment to register, share certificate updates)? Options: Transfer deed/assignment, Amend register/record, Issue new certificate, All of the above
• Are there anti-assignment, tag/drag, or pre-emption rights in fund documents that could block registration? Options: Yes - pre-emption/tag/drag exist, No such restrictions, Unknown - need LPA review
• What KYC/AML and tax documentation will be provided to complete registration (e.g., W-8/W-9, corporate KYC)?
• What is the expected timeline from executed transfer agreement to completed registration on the fund ledger? Options: Less than 1 week, 1-2 weeks, 2-4 weeks, 4+ weeks
• Who will liaise with fund administrators and registrars (buyer, seller, adviser, platform)? Options: Buyer handles liaison, Seller handles liaison, Adviser/platform coordinates, Hybrid - specify

Administer escrow and deferred payments

• Will an escrow account or other payment security be used to hold deferred consideration? Options: Yes - escrow account, Yes - letter of credit or guarantee, No - unsecured deferred payments, Undecided
• What are the release conditions for escrow or deferred tranches (e.g., time-based, performance triggers, tax clearances)? Options: Time-based release, Performance/earnout triggers, Tax/regulatory clearance, Combination
• What term and interest (if any) should apply to deferred payments? Options: Short-term (0-12 months), Medium (12-36 months), Long-term (36+ months), Interest-bearing vs non-interest-bearing
• Which escrow agent or custodian do you prefer, and are they acceptable to counterparties?
• Do deferred payment mechanics require security interests, covenants, or parent guarantees? Options: Security interest required, Parent/company guarantee required, Unsecured, Undecided
• Are there cross-jurisdictional considerations (local law enforcement of escrow, foreign exchange controls) for payment administration? Options: Yes - cross-border issues, No - domestic only, Unsure - need counsel input

• Binding Indicative Term Sheet
• Purchase & Transfer Agreement (Definitive SPA)
• Statement of Work (Transaction SOW)
• Commercial Terms Schedule
• Payment & Funding Instructions
• Escrow & Settlement Agreement
• Deferred Consideration / Earnout Agreement
• Seller Representations & Warranties Schedule
• Conditions Precedent & Closing Checklist
• LP Consent & Transfer Coordination Addendum
• Tax, Regulatory & Compliance Covenants
• Termination, Break Fee & Dispute Resolution Terms
• Closing Deliverables & Post-Close Handover Plan
• Confidentiality & Market Conduct Addendum

• Success Signals Review & Validation
• Payments & Obligations Reconciliation
• Earnouts & Contingent Payments Governance
• Shared Channel & Issues Escalation Setup
• Post-Close Retrospective & Continuous Improvement

• Ensure all relevant stakeholders are scheduled for a short onboarding session to the channel within 5 business days.
• If discrepancies exist, open a remediation ticket and assign to a named owner with a 5-business-day SLA.
• Record and calendar tax reporting deadlines and any required filings resulting from the transaction.
• Current Earnout Status
• Lock the authoritative earnout calculation method, data sources, and owners accountable for each reporting period.
• Establish clear escrow release rules and dispute-resolution SLAs to minimize future friction.
• Agree on a monitoring cadence and reporting template that provides transparency to both buyer and seller.
• Publish an 'Earnout Playbook' containing formulas, data feeds, report templates, and escalation contacts.
• Set up automated data pulls and the first periodic performance report for the upcoming measurement period.
• Establish an independent reviewer (if contractually required) and calendarize dispute windows per contract terms.
• Current Communication Gaps
• Stand up a single authoritative shared channel with access rules and ticketing workflow to manage post-close items.
• Agree SLA targets for responses and resolutions and name escalation owners for each tier.
• Current State Snapshot
• Create the shared workspace and invite stakeholders with defined role-based permissions and a pinned governance doc.
• Deploy the ticketing template (issue type, priority, attachments, deadlines) and run a 30-minute training for users.
• Publish the escalation roster and SLA matrix to the channel and circulate to all parties.
• Current Outcome Recap
• Identify the top 3 process or control changes that will materially reduce future post-close friction.
• Assign owners and timelines for each chosen improvement and schedule follow-up checkpoints.
• Produce updated templates or playbook entries and store them in the shared channel for future deals.
• Document the top 3 prioritized improvements with owners, milestones, and success metrics; circulate the roadmap.
• Update the CustomerNode journey template and transaction playbooks to reflect agreed changes and controls.
• Schedule a 30-day follow-up to review progress on implemented improvements and close any remaining retro items.
• Achieve unanimous stakeholder confirmation that success signals are met or clearly document and quantify any shortfalls.
• Identify and assign remediation owners and timelines for any outstanding items affecting success determination.
• Capture and store validated evidence for audit and future reference in the shared channel.
• Produce a 'Success Report' summarizing each signal, evidence, deviations, and assigned owners (deliver within 3 business days).
• Update the transaction ledger and accounting entries to reflect final reconciled amounts and flag any provisional items.
• Log all signed confirmations (LP consents, escrow releases, settlement advices) into the shared post-close folder.
• Current Cashflow State
• Reconcile 100% of cashflow line items to source documents and obtain finance sign-off for final settlements.
• Identify any shortfalls or overpayments and assign owners/timelines for remediation or recovery.
• Ensure tax and regulatory withholding positions are confirmed and escalation paths are in place for unresolved items.
• Generate and circulate a reconciled payments ledger with bank confirmations and receive sign-off from treasury and seller finance.
• Consequence of Incorrect Calculation
• Consequence Assessment
• Consequence of Mismatch
• Consequence of Poor Governance
• Impact & Consequence Mapping
• Channel Selection & Access Controls
• Defined Future State (Success Criteria Closure)
• Calculation Method & Data Sources
• Final Reconciliation Walkthrough
• Brainstorm Process Improvements
• Ticketing Workflow & SLAs
• Contingent / Deferred Payment Tracking
• Proof Points & Evidence Review
• Decision & Roadmap
• Escrow / Security & Release Conditions
• Knowledge Capture
• Dispute & Adjustment Process
• Forced Validation
• Sign-off & Remittance Instructions
• Escalation Path & Governance Roster
• Monitoring Cadence & Reporting
• Onboarding & Training
• Next Steps & Owners